Using Noncontrast Computed Tomography to Improve Prediction of Intracerebral Hemorrhage Expansion

Background: Noncontrast computed tomography hypodensities are a validated predictor of hematoma expansion (HE) in intracerebral hemorrhage and a possible alternative to the computed tomography angiography (CTA) spot sign but their added value to available prediction models remains unclear. We investigated whether the inclusion of hypodensities improves prediction of HE and compared their added value over the spot sign. Methods: Retrospective analysis of patients admitted for primary spontaneous intracerebral hemorrhage at the following 8 university hospitals in Boston, US (1994–2015, prospective), Hamilton, Canada (2010–2016, retrospective), Berlin, Germany (2014–2019, retrospective), Chongqing, China (2011–2015, retrospective), Pavia, Italy (2017–2019, prospective), Ferrara, Italy (2010–2019, retrospective), Brescia, Italy (2020–2021, retrospective), and Bologna, Italy (2015–2019, retrospective). Predictors of HE (hematoma growth >6 mL and/or >33% from baseline to follow-up imaging) were explored with logistic regression. We compared the discrimination of a simple prediction model for HE based on 4 predictors (antitplatelet and anticoagulant treatment, baseline intracerebral hemorrhage volume, and onset-to-imaging time) before and after the inclusion of noncontrast computed tomography hypodensities, using receiver operating characteristic curve and De Long test for area under the curve comparison. Results: A total of 2465 subjects were included, of whom 664 (26.9%) had HE and 1085 (44.0%) had hypodensities. Hypodensities were independently associated with HE after adjustment for confounders in logistic regression (odds ratio, 3.11 [95% CI, 2.55–3.80]; P<0.001). The inclusion of noncontrast computed tomography hypodensities improved the discrimination of the 4 predictors model (area under the curve, 0.67 [95% CI, 0.64–0.69] versus 0.71 [95% CI, 0.69–0.74]; P=0.025). In the subgroup of patients with a CTA available (n=895, 36.3%), the added value of hypodensities remained statistically significant (area under the curve, 0.68 [95% CI, 0.64–0.73] versus 0.74 [95% CI, 0.70–0.78]; P=0.041) whereas the addition of the CTA spot sign did not provide significant discrimination improvement (area under the curve, 0.74 [95% CI, 0.70–0.78]). Conclusions: Noncontrast computed tomography hypodensities provided a significant added value in the prediction of HE and appear a valuable alternative to the CTA spot sign. Our findings might inform future studies and suggest the possibility to stratify the risk of HE with good discrimination without CTA.

[1]  A. Charidimou,et al.  Noncontrast Computed Tomography Markers of Cerebral Hemorrhage Expansion: Diagnostic Accuracy Meta-Analysis , 2022 .

[2]  J. Mocco,et al.  2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage: A Guideline From the American Heart Association/American Stroke Association. , 2022, Stroke.

[3]  Arba Francesco,et al.  Noncontrast Computed Tomography Markers of Cerebral Hemorrhage Expansion: Diagnostic Accuracy Meta-Analysis. , 2021, International journal of stroke : official journal of the International Stroke Society.

[4]  C. Anderson,et al.  Early lowering of blood pressure after acute intracerebral haemorrhage: a systematic review and meta-analysis of individual patient data , 2021, Journal of Neurology, Neurosurgery, and Psychiatry.

[5]  G. Donnan,et al.  Mobile Stroke Units Facilitate Prehospital Management of Intracerebral Hemorrhage , 2021, Stroke.

[6]  S. Greenberg,et al.  Hematoma Expansion in Intracerebral Hemorrhage With Unclear Onset , 2021, Neurology.

[7]  Sung-Chun Tang,et al.  Tranexamic acid in patients with intracerebral haemorrhage (STOP-AUST): a multicentre, randomised, placebo-controlled, phase 2 trial , 2020, The Lancet Neurology.

[8]  A. Charidimou,et al.  Noncontrast CT markers of intracerebral hemorrhage expansion and poor outcome , 2020, Neurology.

[9]  G. Schön,et al.  Inter- and Intrarater Agreement of Spot Sign and Noncontrast CT Markers for Early Intracerebral Hemorrhage Expansion , 2020, Journal of clinical medicine.

[10]  D. Fergusson,et al.  Evaluating Hematoma Expansion Scores in Acute Spontaneous Intracerebral Hemorrhage , 2019, Stroke.

[11]  C. Anderson,et al.  Blood pressure control and clinical outcomes in acute intracerebral haemorrhage: a preplanned pooled analysis of individual participant data , 2019, The Lancet Neurology.

[12]  A. Demchuk,et al.  Effect of Recombinant Activated Coagulation Factor VII on Hemorrhage Expansion Among Patients With Spot Sign-Positive Acute Intracerebral Hemorrhage: The SPOTLIGHT and STOP-IT Randomized Clinical Trials. , 2019, JAMA neurology.

[13]  A. Demchuk,et al.  Interrater and Intrarater Measurement Reliability of Noncontrast Computed Tomography Predictors of Intracerebral Hemorrhage Expansion , 2019, Stroke.

[14]  A. Demchuk,et al.  Standards for Detecting, Interpreting and Reporting NCCT Markers of ICH Expansion. , 2019, Annals of neurology.

[15]  Craig S Anderson,et al.  Intracerebral haemorrhage: current approaches to acute management. , 2018, Lancet.

[16]  Y. Fujii,et al.  Absolute risk and predictors of the growth of acute spontaneous intracerebral haemorrhage: a systematic review and meta-analysis of individual patient data , 2018 .

[17]  S. Greenberg,et al.  Integration of Computed Tomographic Angiography Spot Sign and Noncontrast Computed Tomographic Hypodensities to Predict Hematoma Expansion , 2018, Stroke.

[18]  Correction to: 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. , 2018, Stroke.

[19]  S. Greenberg,et al.  Intensive Blood Pressure Reduction and Spot Sign in Intracerebral Hemorrhage: A Secondary Analysis of a Randomized Clinical Trial , 2017, JAMA neurology.

[20]  Assa Doron,et al.  Mobile , 2017 .

[21]  A. Charidimou,et al.  Noncontrast Computed Tomography Markers of Intracerebral Hemorrhage Expansion. , 2017, Stroke.

[22]  S. Greenberg,et al.  Association Between Hypodensities Detected by Computed Tomography and Hematoma Expansion in Patients With Intracerebral Hemorrhage. , 2016, JAMA neurology.

[23]  S. Greenberg,et al.  Effect of CTA Tube Current on Spot Sign Detection and Accuracy for Prediction of Intracerebral Hemorrhage Expansion , 2016, American Journal of Neuroradiology.

[24]  A. Demchuk,et al.  Evolution of Computed Tomography Angiography Spot Sign Is Consistent With a Site of Active Hemorrhage in Acute Intracerebral Hemorrhage , 2014, Stroke.

[25]  R. Gonzalez,et al.  Prospective Validation of the Computed Tomographic Angiography Spot Sign Score for Intracerebral Hemorrhage , 2013, Stroke.

[26]  S. Greenberg,et al.  Predictors of hematoma volume in deep and lobar supratentorial intracerebral hemorrhage. , 2013, JAMA neurology.

[27]  A. Demchuk,et al.  Prediction of haematoma growth and outcome in patients with intracerebral haemorrhage using the CT-angiography spot sign (PREDICT): a prospective observational study , 2012, The Lancet Neurology.

[28]  Eric E. Smith,et al.  Defining hematoma expansion in intracerebral hemorrhage , 2011, Neurology.

[29]  C. Anderson,et al.  Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2010, Stroke.

[30]  A. Qureshi Antihypertensive treatment of acute cerebral hemorrhage* , 2010, Critical care medicine.

[31]  S. Mayer,et al.  Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. , 2008, The New England journal of medicine.

[32]  S. Pocock,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2007, Preventive medicine.

[33]  S. Greenberg,et al.  Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage , 2004, Neurology.

[34]  J. Goo,et al.  SRA 626 : Statistical Analysis , 2004 .

[35]  E. DeLong,et al.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.

[36]  C. Fisher,et al.  PATHOLOGICAL OBSERVATIONS IN HYPERTENSIVE CEREBRAL HEMORRHAGE , 1971, Journal of neuropathology and experimental neurology.